|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/12 | |
| A61K 39/085 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2860191 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14195810.8 |
| Europos patento paraiškos padavimo data | 2010-08-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 09010311 | 2009-08-10 | EP | |
| 266330 P | 2009-12-03 | US |
| (72) |
Rudolf, Michael, CH
Koch, Holger, CH
|
| (73) |
Aridis Pharmaceuticals, Inc.,
5941 Optical Court, San Jose, CA 95138,
US
|
| (54) | Human monoclonal antibody against S. aureus derived alpha-toxin and its use in treating or preventing abscess formation |
| Human monoclonal antibody against S. aureus derived alpha-toxin and its use in treating or preventing abscess formation |